Position in NRIX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$9,446,455
+$2,046,600 QoQ
Shares Held
389,384
-18.4% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. NRIX ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,446,455 | 389,384 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $7,399,855 | 477,410 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,245,803 | 171,102 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $68,070 | 7,367 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $498,049 | 43,727 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,668,735 | 140,466 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,022,472 | 107,350 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,114,354 | 49,593 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $572,296 | 27,422 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $2,716,265 | 184,780 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $156,295 | 15,145 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $331,691 | 42,200 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $469,130 | 46,960 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,004,363 | 113,104 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $808,084 | 73,596 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,570,349 | 120,518 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $953,607 | 75,265 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $352,771 | 25,180 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,217,888 | 76,611 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $3,614,733 | 120,652 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $3,250,216 | 122,511 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $2,635,064 | 84,756 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $115,540 | 3,514 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $18,607 | 533 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||